Literature DB >> 19647927

Cervical spondylotic amyotrophy presenting as dropped head syndrome.

Rechdi Ahdab1, Alain Créange, Sandrine Benaderette, Jean-Pascal Lefaucheur.   

Abstract

We report a case of acute-onset dropped head syndrome in a 65-year-old patient in whom the diagnosis of amyotrophic lateral sclerosis (ALS) was initially proposed based on electromyographic signs of neck and shoulder muscle denervation. There were no signs of pyramidal involvement and the clinical and electromyographic signs of motor denervation never evolved beyond the neck and shoulder girdle muscles after a 6-year follow-up period, which argued against ALS. Other causes of dropped head syndrome were carefully ruled out based on clinical findings, electrodiagnostic studies and blood investigations. The restriction of muscle denervation to a few cervical myotomes, the presence of C3-C4 spondylotic changes without associated root or spinal cord compression, and the absence of an alternative explanation to the patient's symptoms strongly supported the diagnosis of cervical spondylotic amyotrophy (CSA). CSA is thought to result from spinal cord microcirculatory disturbances and secondary anterior horn cell degeneration due to ischemia. Our case enlarges the clinical spectrum of focal cervical anterior horn disease, which classically results in more distal monomelic atrophy affecting one or both upper limbs.

Entities:  

Mesh:

Year:  2009        PMID: 19647927     DOI: 10.1016/j.clineuro.2009.07.005

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

Review 1.  Cervical spondylotic amyotrophy.

Authors:  Sheng-Dan Jiang; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Eur Spine J       Date:  2010-08-08       Impact factor: 3.134

2.  Cervical spondylotic amyotrophy: a systematic review.

Authors:  Wenqi Luo; Yueying Li; Qinli Xu; Rui Gu; Jianhui Zhao
Journal:  Eur Spine J       Date:  2019-04-29       Impact factor: 3.134

3.  Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.

Authors:  Carmen Alcalá; Carlos Quintanilla-Bordás; Francisco Gascón; Ángel Perez Sempere; Laura Navarro; María Carcelén-Gadea; Lamberto Landete; Javier Mallada; Emmanuel Cañizares; Antonio Belenguer; Sara Carratalá; José Andrés Domínguez; Francisco Carlos Pérez-Miralles; Sara Gil-Perotín; Raquel Gasqué; Laura Cubas; Jéssica Castillo; Bonaventura Casanova
Journal:  J Neurol       Date:  2022-02-02       Impact factor: 4.849

4.  Evaluation of characteristics and surgical outcomes in cervical spondylotic amyotrophy.

Authors:  Hong-Li Wang; Heng-Chao Li; Jian-Yuan Jiang; Fei-Zhou Lū; Wen-Jun Chen; Xiao-Sheng Ma
Journal:  Indian J Orthop       Date:  2014-09       Impact factor: 1.251

5.  Cervical Spondylotic Amyotrophy: Case Series and Review of the Literature.

Authors:  Toshiyuki Takahashi; Junya Hanakita; Manabu Minami; Yosuke Tomita; Tomoki Sasagasako; Ryo Kanematsu
Journal:  Neurospine       Date:  2019-09-30

6.  Dropped head syndrome: diagnosis and management.

Authors:  Allan R Martin; Rajesh Reddy; Michael G Fehlings
Journal:  Evid Based Spine Care J       Date:  2011-05

7.  Surgical treatment for dropped head syndrome with cervical spondylotic amyotrophy: a case report.

Authors:  Shinji Taniguchi; Hiroshi Takahashi; Yasuchika Aoki; Arata Nakajima; Fumiaki Terajima; Masato Sonobe; Yorikazu Akatsu; Manabu Yamada; Takeo Furuya; Masao Koda; Masashi Yamazaki; Seiji Ohtori; Koichi Nakagawa
Journal:  BMC Res Notes       Date:  2018-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.